03-18 Public Joint Stock Company "Farmak" announces Annual dividend CI
25/09/25 Public Joint Stock Company "Farmak" announces Annual dividend, payable on October 21, 2025 CI
05/05/25 Public Joint Stock Company "Farmak" announces Annual dividend, payable on May 05, 2025 CI
27/03/24 Public Joint Stock Company "Farmak" acquired Symphar Sp Z O O. CI
31/05/23 Public Joint Stock Company "Farmak" acquired Ukrainian business of Novator’s portfolio company from Novator Partners LLP. CI
31/05/23 Public Joint Stock Company "Farmak" acquired Two pharmaceutical marketing companies in the Czech Republic and Slovakia of Novator. CI
13/12/22 Altris, Inc announced that it has received $1 million in funding from a group of investors CI
07/12/21 DrugCard announced that it has received €0.255 million in funding from Public Joint Stock Company "Farmak", Think Bigger Capital, SGEIC, S.A. CI
03/12/21 Public Joint Stock Company "Farmak" Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
29/06/21 ComeBack Mobility announced that it has received $1 million in funding from Fison, Public Joint Stock Company "Farmak", and other investors CI
29/04/21 Public Joint Stock Company Farmak Reports Earnings Results for the Full Year Ended December 31, 2020 CI
06/12/20 Bicovery announced that it has received $0.05 million in funding from Public Joint Stock Company "Farmak" CI
06/12/20 ComeBack Mobility announced that it has received $0.13 million in funding from Public Joint Stock Company "Farmak" and other investors CI
Manager TitleAgeSince
Chief Executive Officer 40 15/03/2018
Director of Finance/CFO - 30/09/2024
Chief Tech/Sci/R&D Officer - 31/05/2008
Director TitleAgeSince
Chairman 76 31/12/2006
Director/Board Member - 18/04/2018
Director/Board Member 65 06/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 109M
+0.42%+2.68%+14.11%+83.10% 48B
+3.36%+7.21%+72.47%+121.55% 36.89B
+0.97%+2.24%-2.71%+45.66% 12.37B
+0.64%+4.22%+14.68%+96.22% 11.95B
+0.97%+0.58%+32.90%+119.07% 9.01B
+0.90%+1.91%+22.51%+47.75% 7.2B
+1.22%+2.99%+54.53%-6.03% 7.05B
-0.62%+32.11%-16.02%+21.06% 6.58B
+2.71%+5.41%+24.07%+242.00% 6.55B
Average +0.96%+4.59%+24.06%+85.60% 16.18B
Weighted average by Cap. +1.33%+3.49%+30.13%+91.25%
Logo Farmak
Farmak PAT (Farmak OJSC) is a Ukraine-based company involved in the chemical and pharmaceutical industry. The Company's product portfolio includes approximately 150 names in various dosage forms: parenteral dosage forms, drops, ointments, tablets and capsules. It is also involved in the production of pharmaceuticals for veterinarian use, pharmaceutical substances synthesis, contract manufacturing, and scientific research. The Company owns such facilities as equipment for labeling and packaging ampoules, production section for drags dosage forms of medicines, and a workshop for ointments, creams, pastes, and gels. Farmak PAT operates on the markets of Ukraine, the Baltic countries, Bulgaria, the Commonwealth of Independent States countries and Poland.
Employees
2,931
  1. Stock Market
  2. Stocks
  3. FARM Stock